Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden
· Delayed Price · Currency is SEK 0.3700
+0.0850 (29.82%)
Jun 25, 2025, 4:49 PM CET
Spago Nanomedical AB Revenue
Spago Nanomedical AB had revenue of 1.51M SEK in the quarter ending March 31, 2025, with 5.60% growth. This brings the company's revenue in the last twelve months to 6.73M, up 17.67% year-over-year. In the year 2024, Spago Nanomedical AB had annual revenue of 6.65M with 17.94% growth.
Revenue (ttm)
6.73M
Revenue Growth
+17.67%
P/S Ratio
14.74
Revenue / Employee
748.22K
Employees
13
Market Cap
99.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.65M | 1.01M | 17.94% |
| Dec 31, 2023 | 5.64M | -562.00K | -9.06% |
| Dec 31, 2022 | 6.20M | -279.00K | -4.30% |
| Dec 31, 2021 | 6.48M | -679.00K | -9.48% |
| Dec 31, 2020 | 7.16M | -11.80M | -62.23% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.31B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |